Phase 2 Gastric Cancer Stage Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study
Peritoneal Metastases From Gastric CancerGastric Cancer Stage IVGastric or Esophagogastric Junction Adenocarcinoma
Ruijin Hospital74 enrolled1 locationNCT07556640
Recruiting
Phase 2
HEARTS Trial for Thoracic Cancers
Non-Small Cell Lung Cancer (Stage III)Esophageal Cancer Stage I-IIIEsophagogastric Cancer Stage I-III+2 more
University of Wisconsin, Madison60 enrolled1 locationNCT07132918
Recruiting
Phase 2
Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis
Peritoneal MetastasesGastric Cancer Stage IV
Ruijin Hospital40 enrolled1 locationNCT06519591
Recruiting
Phase 1Phase 2
Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer
Gastric Cancer Stage IV
Yonsei University71 enrolled1 locationNCT04592211
Recruiting
Phase 1Phase 2
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
Gastric Cancer Stage IV
Fujian Cancer Hospital51 enrolled1 locationNCT05319639
Recruiting
Phase 2
Exploratory Single-arm, Single-center Adjuvant Treatment of Stage IIIB-IIIC Gastric Cancer With Combination of Palizumab and SOX Regimen
Gastric Cancer Stage IIIB-IIIC
Shanghai Minimally Invasive Surgery Center20 enrolled1 locationNCT06036745